Page last updated: 2024-11-02

pipobroman and Leukemia, Acute Monocytic

pipobroman has been researched along with Leukemia, Acute Monocytic in 1 studies

Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.

Research Excerpts

ExcerptRelevanceReference
"A trial was conducted between 1970 and 1981 with pipobroman (PB) in 100 consecutive patients with polycythemia vera (PV), followed for a median time of 60 months, to evaluate the efficacy of this drug and assess the risk of acute leukemia."9.05Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia. ( Bernasconi, C; Brusamolino, E; Canevari, A; Salvaneschi, L, 1984)
"A trial was conducted between 1970 and 1981 with pipobroman (PB) in 100 consecutive patients with polycythemia vera (PV), followed for a median time of 60 months, to evaluate the efficacy of this drug and assess the risk of acute leukemia."5.05Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia. ( Bernasconi, C; Brusamolino, E; Canevari, A; Salvaneschi, L, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brusamolino, E1
Salvaneschi, L1
Canevari, A1
Bernasconi, C1

Trials

1 trial available for pipobroman and Leukemia, Acute Monocytic

ArticleYear
Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Leukemia, Monocytic, Acute; Leukemia, M

1984